GLAXOSMITHKLINE, LLC Federal Contracts — Government Award History
Total (All Time)$4.0B
Latest FY$592,255
Primary AgencyDepartment of Health and Human Services
GLAXOSMITHKLINE, LLC has received $4.0B in total federal contract awards
across 13 fiscal year(s). ▼ 96.9% vs FY2025 Peak year was FY2022 ($1.7B).
Primary awarding agency: Department of Health and Human Services.
Data covers largest contracts by award amount. Source: USASpending.gov (FPDS).
Awards by Fiscal Year
| Year | Spending | Total | Contracts | Top Agency |
|---|---|---|---|---|
| FY2026 | $592,255 | 5건 | Department of Health and Human Services | |
| FY2025 | $19.2M | 8건 | Department of Health and Human Services | |
| FY2024 | $68.7M | 49건 | Department of Health and Human Services | |
| FY2023 | $11.9M | 11건 | Department of Health and Human Services | |
| FY2022 | $1664.6M | 85건 | Department of Defense | |
| FY2021 | $312.7M | 18건 | Department of Defense | |
| FY2020 | $351.1M | 8건 | Department of Defense | |
| FY2019 | $6.6M | 7건 | Department of Health and Human Services | |
| FY2018 | $15.0M | 6건 | Department of Health and Human Services | |
| FY2017 | $1286.0M | 12건 | Department of Health and Human Services | |
| FY2016 | $135.3M | 12건 | Department of Health and Human Services | |
| FY2015 | $23.2M | 6건 | Department of Health and Human Services | |
| FY2013 | $89.1M | 3건 | Department of Health and Human Services |
Notable Contracts
| Date | Agency | Amount | Description |
|---|---|---|---|
| 2021-11-15 | Department of Defense | $1597.5M | :COVID-19: SOTROVIMAB MONOCLONAL ANDTIBODIES |
| 2017-04-01 | Department of Health and Human Services | $1085.9M | IGF::OT::IGF VACINES FOR CHILDREN |
| 2012-04-01 | Department of Health and Human Services | $741.8M | VACCCINE FOR CHILDREN 2012 |
| 2014-04-01 | Department of Health and Human Services | $688.4M | VACCINE FOR CHILDREN (VFC) 2014 |
| 2020-07-30 | Department of Defense | $346.1M | GLAXOSMITHKLINE ADJUVANT AS03 |
| 2021-09-24 | Department of Defense | $279.9M | :COVID-19: MONOCLONAL ANTIBODY (MAB) THERAPEUTIC SOTROVIMAB |
| 2016-12-23 | Department of Health and Human Services | $102.2M | IGF:OT:IGF 2017 ADULT FLU |
| 2017-07-01 | Department of Health and Human Services | $84.7M | 2017 ADULT VACCINES |
| 2014-02-05 | Department of Health and Human Services | $81.5M | PEDIATRIC FLU VACCINES 2014-2015 |
| 2015-12-18 | Department of Health and Human Services | $69.9M | IGF::OT::IGF 2016 PED FLU |
| 2013-02-22 | Department of Health and Human Services | $55.0M | PEDIATRIC FLU VACCINE |
| 2012-07-06 | Department of Health and Human Services | $50.8M | 2012 ADULT VACCINES |
| 2016-07-01 | Department of Health and Human Services | $50.6M | IGF::OT::IGF 2016 VFA – GSK |
| 2013-07-01 | Department of Health and Human Services | $31.2M | VACCINE FOR ADULTS 2013 |
| 2022-09-14 | Department of Health and Human Services | $22.9M | THE PURPOSE OF THIS TASK ORDER IS TO PROCURE INFLUENZA A/ASTRAKHAN/3212/2020 (H5 |
| 2015-02-06 | Department of Health and Human Services | $20.1M | 2015-2016 ADULT FLU VACCINES |
| 2022-08-31 | Department of Defense | $18.8M | 8508921650!INFLUENZA VIRUS VAC |
| 2024-05-10 | Department of Health and Human Services | $18.4M | THIS TASK ORDER ESTABLISHES SERVICES FOR H5 PANDEMIC READINESS FOR ACQUISITION O |
| 2021-02-26 | Department of Defense | $17.5M | 8508019609!INFLUENZA VIRUS VAC |
| 2024-02-27 | Department of Health and Human Services | $15.4M | THE PURPOSE OF THIS TASK ORDER IS TO ESTABLISH FILL/FINISH ACTIVITIES FOR ADJUVA |